Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model.

Novalić, Zlata

Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model. [electronic resource] - Journal of medical virology 12 2017 - 2207-2216 p. digital

Publication Type: Journal Article

1096-9071

10.1002/jmv.24870 doi


Animals
Antiviral Agents--blood
Carcinoma--drug therapy
DNA, Viral--genetics
Deoxycytidine--analogs & derivatives
Disease Models, Animal
Epstein-Barr Virus Infections--complications
Ganciclovir--administration & dosage
Herpesvirus 4, Human--drug effects
Humans
Mice
Mice, Nude
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms--drug therapy
Treatment Outcome
Tumor Cells, Cultured
Valproic Acid--pharmacology
Viral Load--methods
Virus Activation
Gemcitabine